Yoshifumi Saisho

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 15

Top Topics

Dna Methylation

Glycemic Control

Coronavirus Disease

Top Venues

Journal of diabetes investigation

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Jun Inaishi, Yoshifumi Saisho
Exenatide Once Weekly for Management of Type 2 Diabetes: A Review. Clinical pharmacology : advances and applications 14 (2022)
Yoshifumi Kasuga, Tomoko Kawai, Kei Miyakoshi, Asuka Hori, Masumi Tamagawa, Keita Hasegawa, Satoru Ikenoue, Daigo Ochiai, Yoshifumi Saisho, Mariko Hida, Mamoru Tanaka, Kenichiro Hata
DNA methylation analysis of cord blood samples in neonates born to gestational diabetes mothers diagnosed before 24 gestational weeks. BMJ open diabetes research & care 10 (1) (2022)
Yoshifumi Kasuga, Yoshifumi Saisho, Masumi Tamagawa, Satoru Ikenoue, Mamoru Tanaka, Daigo Ochiai
New strategy for diagnosing abnormal glucose tolerance before 24 gestational weeks during the coronavirus disease 2019 pandemic. Journal of diabetes investigation 12 (11) (2021)
Kazutoshi Sugiyama, Yoshifumi Saisho
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults. Diabetologia 65 (1) (2021)
Kazutoshi Sugiyama, Yoshifumi Saisho, Yoshifumi Kasuga, Daigo Ochiai, Hiroshi Itoh
Clinical utility of 1-month postpartum random plasma glucose and glycated hemoglobin combined with pre-pregnancy body mass index for detecting postpartum glucose intolerance in Japanese women with gestational diabetes. Journal of diabetes investigation (2021)
Hironobu Sasaki, Yoshifumi Saisho, Jun Inaishi, Yuusuke Watanabe, Tami Tsuchiya, Masayoshi Makio, Midori Sato, Masaru Nishikawa, Minoru Kitago, Taketo Yamada, Hiroshi Itoh
Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes. Diabetologia 64 (8) (2021)
Hironobu Sasaki, Yoshifumi Saisho, Jun Inaishi, Hiroshi Itoh
Revisiting Regulators of Human β-cell Mass to Achieve β-cell-centric Approach Toward Type 2 Diabetes. Journal of the Endocrine Society 5 (10) (2021)
Jun Inaishi, Yoshifumi Saisho
Beta-Cell Mass in Obesity and Type 2 Diabetes, and Its Relation to Pancreas Fat: A Mini-Review. Nutrients 12 (12) (2020)
Yoshifumi Saisho
An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective. Expert opinion on pharmacotherapy 21 (13) (2020)
Hironobu Sasaki, Yoshifumi Saisho, Jun Inaishi, Yuusuke Watanabe, Tami Tsuchiya, Masayoshi Makio, Midori Sato, Minoru Kitago, Taketo Yamada, Hiroshi Itoh
Associations of birthweight and history of childhood obesity with beta cell mass in Japanese adults. Diabetologia 63 (6) (2020)
Yuusuke Watanabe, Yoshifumi Saisho, Jun Inaishi, Kinsei Kou, Akira Yamauchi, Yasuhiko Kanazawa, Yoshiaki Okubo, Mikiya Tokui, Takatoshi Imai, Rie Murakami, Tami Tsuchiya, Hironobu Sasaki, Tatsuhiro Masaoka, Junichiro Irie, Shu Meguro, Hiroshi Itoh, null null
Efficacy and safety of once-weekly exenatide after switching from twice-daily exenatide in patients with type 2 diabetes. Journal of diabetes investigation 11 (2) (2019)
Taichi Nagahisa, Yoshifumi Saisho
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders 10 (5) (2019)
Yoshifumi Saisho
Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. International journal of environmental research and public health 15 (5) (2018)
Kazutoshi Sugiyama, Yoshifumi Saisho
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment. Diseases (Basel, Switzerland) 6 (2) (2018)
Yoshifumi Kasuga, Kei Miyakoshi, Atsushi Tajima, Yoshifumi Saisho, Satoru Ikenoue, Daigo Ochiai, Tadashi Matsumoto, Naoko Arata, Kenichiro Hata, Mamoru Tanaka
Clinical and genetic characteristics of abnormal glucose tolerance in Japanese women in the first year after gestational diabetes mellitus. Journal of diabetes investigation 10 (3) (2018)